Araştırma Makalesi

Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer's Disease Treatment

Cilt: 27 Sayı: Ek Sayı 1 (Suppl 1) 25 Aralık 2024
PDF İndir
TR EN

Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer's Disease Treatment

Abstract

Alzheimer’s Disease (AD) is a debilitating neurodegenerative condition with limited treatment options. Lignans, a class of naturally occurring polyphenols found in various plants, have been shown to have the potential to modulate pathways associated with AD pathology. In this study, we used network pharmacology and molecular docking to investigate the therapeutic potential of lignans against AD by targeting specific proteins involved in disease progression. Our established interaction network includes key proteins such as EGFR, HSP90AA1, BCL2, HSP90AB1, IL6, JUN, ESR1, PIK3CA, ERBB2, and PIK3R1. Molecular docking studies have revealed how lignans interact with these proteins and highlighted their potential to influence AD through mechanisms such as inflammation modulation, apoptosis regulation, and signal transduction pathways. The results suggest that lignans have significant binding abilities to these targets, potentially inhibiting their activity and thus alleviating AD symptoms by reducing amyloid-beta accumulation and tau phosphorylation. These findings support the viability of lignans as a basis for the development of new AD therapies and call for further in vivo studies to confirm their efficacy and safety. This integrated approach underscores the value of combining network pharmacology and molecular docking in the search for new therapeutic agents against complex diseases such as AD.

Keywords

Etik Beyan

An ethics committee permission is not required for the article.

Kaynakça

  1. Abadi, A.M., Zaki, M.S.A., Sideeg, A.M., El, A.F., & Guo, X. (2024). Determination of cytotoxicity, biological effects and anti-human breast cancer properties of Bilobol. Iranian Journal of Chemistry and Chemical Engineering (IJCCE), 1, 1-24.
  2. Abd El-Razek, M.H., Eissa, I.H., Al-Karmalawy, A.A., Elrashedy, A.A., El-Desoky, A.H., Aboelmagd, M., Mohamed, T.A., Hegazy, M.E.F. (2024). epi-Magnolin, a tetrahydrofurofuranoid lignan from the oleo-gum resin of Commiphora wightii, as inhibitor of pancreatic cancer cell proliferation, in-vitro and in-silico study. Journal of Biomolecular Structure and Dynamics, 1, 1-13.
  3. Abdul, H., Butterfield, D. (2007). Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Free Radical Biology & Medicine, 42(3), 371-84.
  4. Aguilar-Carrillo, Y., Soto-Urzúa, L., Martínez-Martínez, M.D.L.Á., Becerril-Ramírez, M., Martínez-Morales, L.J. (2024). Computational analysis of the tripartite interaction of phasins (PhaP4 and 5)-sigma factor (σ24)-DNA of Azospirillum brasilense Sp7. Polymers, 16(5), 611.
  5. Ahsan, A., Ramanand, S., Whitehead, C., Hiniker, S., Rehemtulla, A., Pratt, W., Jolly, S., Gouveia, C., Truong, K., Waes, C., Ray, D., Lawrence, T., Nyati, M. (2012). Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors. Neoplasia, 14(8),670-677 .
  6. Alam, M., Ali, S., Mohammad, T., Hasan, G.M., Yadav, D.K., Hassan, M.I. (2021). B cell lymphoma 2: a potential therapeutic target for cancer therapy. International Journal of Molecular Sciences, 22(19), 10442.
  7. Arjmandi-Rad, S., Vestergaard Nieland, J.D., Goozee, K.G., Vaseghi, S. (2024). The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer’s disease: A systematic review. Neurological Sciences, 45(2), 417-430.
  8. Astillero‐Lopez, V., Villar‐Conde, S., Gonzalez‐Rodriguez, M., Flores‐Cuadrado, A., Ubeda‐Banon, I., Saiz‐Sanchez, D., Martinez‐Marcos, A. (2024). Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells. Brain Pathology, e13235.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Farmasotik Botanik

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

15 Eylül 2024

Yayımlanma Tarihi

25 Aralık 2024

Gönderilme Tarihi

27 Mayıs 2024

Kabul Tarihi

14 Ağustos 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 27 Sayı: Ek Sayı 1 (Suppl 1)

Kaynak Göster

APA
Şirin, S., & Niğdelioğlu Dolanbay, S. (2024). Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer’s Disease Treatment. Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi, 27(Ek Sayı 1 (Suppl 1), 35-58. https://doi.org/10.18016/ksutarimdoga.vi.1490753

Cited By

21082



2024-JIF = 0.500

2024-JCI = 0.14

Uluslararası Hakemli Dergi (International Peer Reviewed Journal)

       Dergimiz, herhangi bir başvuru veya yayımlama ücreti almamaktadır. (Free submission and publication)

      Yılda 6 sayı yayınlanır. (Published 6 times a year)


88x31.png 

Bu web sitesi Creative Commons Atıf 4.0 Uluslararası Lisansı ile lisanslanmıştır.

                 


Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi
e-ISSN: 2619-9149